Understanding Site Qualification Visits (SQV) in Clinical Trials: A Guide for Sites and Researchers
Key Takeaways
A site qualification visit helps sponsors and CROs assess a site's readiness for a particular study.
The visit may include staff discussions, document reviews, and a tour of the research facilities.
Investigators should prepare relevant qualifications, training records, facility information, and study-related documentation.
A site qualification visit checklist helps teams organize their preparation.
Successful qualification may lead to further study startup activities, but it does not automatically authorize participant enrolment.
Quick Answer
A site qualification visit (SQV) is an assessment conducted by a clinical trial sponsor or contract research organization (CRO). It helps determine whether a research site has the qualified staff, facilities, equipment, and operational resources needed to conduct a specific clinical trial.
Introduction
A research site may have an experienced investigator, a capable team, and suitable facilities, but how does it demonstrate that everything is ready for a particular clinical trial? That is where a site qualification visit in clinical trials (SQV) comes in.
Before moving forward with a prospective site, a sponsor or CRO may arrange a visit to understand how the research team operates, review its resources, and discuss whether it can meet the study's requirements.
For site owners and researchers, this meeting is more than a facility tour. It is an opportunity to explain existing processes, demonstrate staff capabilities, and address questions about conducting the proposed study.
Understanding what happens during a site qualification visit and preparing for it can help research teams approach the assessment with clarity and confidence.
What Is a Site Qualification Visit in Clinical Trials?
A site qualification visit in clinical trials is a pre-study assessment conducted by a sponsor or CRO to evaluate a research site's ability to conduct a proposed clinical trial.
During the visit, the sponsor or CRO meets with the investigator and relevant staff. The team also reviews the site's resources, facilities, and operational processes to understand whether they meet the study's requirements.
Unlike the broader clinical trial site selection process, which covers how sponsors identify and evaluate potential research locations, an SQV focuses on verifying a prospective site's capabilities through direct discussion and assessment.
What Is the Purpose of an SQV?
The main purpose is to determine whether the site can carry out the study as planned while meeting applicable ethical, regulatory, and protocol requirements. The assessment may cover:
The investigator's qualifications and availability.
Research staff experience and training.
Facilities, equipment, and storage arrangements.
Patient access and recruitment capabilities.
Documentation and operational procedures.
Relevant ethics and regulatory processes.
The exact assessment depends on the protocol, study complexity, and sponsor expectations. Some visits take place in person, while others may be conducted remotely.
When Does a Site Qualification Visit Take Place, and Who Is Involved?
A site qualification visit in clinical trials generally takes place after a sponsor or CRO has reviewed initial site information and determined that further assessment is appropriate. Additionally, it may follow a feasibility questionnaire or an initial discussion with the investigator.
The timing can vary. However, the visit usually occurs before the site is formally selected and proceeds through later study startup activities. A pre-study visit in clinical research may also be referred to as a site selection visit, depending on the sponsor's terminology.
Who Participates in the Visit?
The visiting team usually includes a sponsor representative or a clinical research associate (CRA) working for the sponsor or CRO. On the site's side, the following individuals may participate:
Principal Investigator (PI): Explains clinical oversight, relevant experience, and availability for the proposed study. Understanding the role of the principal investigator helps clarify why the PI's involvement matters during the assessment.
Clinical Research Coordinator (CRC): Discusses daily research operations, participant scheduling, documentation, and coordination with the study team.
Sub-investigators: Provide information about their qualifications and responsibilities, where applicable.
Supporting department representatives: Pharmacy, laboratory, imaging, or other personnel may attend when their services are needed for the protocol.
Not every person needs to attend every SQV. The sponsor or CRO will generally identify the key participants based on the study's requirements.
What Happens During a Site Qualification Visit in Clinical Trials?
A site qualification visit in clinical trials usually combines discussion, documentation review, and a walkthrough of the facilities. The visiting team wants to understand how the site would manage the proposed trial in practice.
1. Opening Discussion and Study Overview
The visit may begin with an overview of the protocol, including its objectives, participant eligibility criteria, study procedures, and expected enrollment. The PI and research team can discuss their understanding of the study and identify any questions about its requirements.
This is also a useful time to clarify responsibilities, anticipated workload, and the availability of staff.
2. Site Tour and Operational Review
The sponsor or CRO representative may request a tour of the areas that would support study activities. Depending on the protocol, these may include:
Examination and consultation rooms.
Laboratory and specimen-processing areas.
Pharmacy or investigational product storage areas.
Equipment and supply storage.
Research staff workspaces.
Areas used for participant assessments.
The team may ask how equipment is maintained, how supplies are stored, and whether access to restricted areas is controlled.
3. Questions and Documentation Review
The visiting representative may review relevant documents and ask how the site handles research activities. Discussions can cover staff training, standard operating procedures (SOPs), informed consent processes, source documentation, safety reporting, and record retention.
The team should be prepared to explain its actual procedures rather than simply confirm that documents exist.
What Do Sponsors and CROs Assess During an SQV?
The assessment focuses on whether the site can meet the study's specific requirements. Sponsors and CROs typically review four key areas.
Investigator Qualifications and Experience
The PI's education, professional qualifications, research experience, and availability may be reviewed. They should also understand the protocol and be prepared to discuss medical oversight and participant safety.
Staff Experience and Training
The visiting team may review staff qualifications, training records, and assigned responsibilities. This includes coordinators, nurses, and sub-investigators involved in the study.
Facilities and Equipment
The site must have suitable space and equipment for the study procedures. Depending on the protocol, this may include examination rooms, laboratory facilities, specimen storage, and imaging equipment. Maintenance and calibration records may also be checked.
Documentation and Research Procedures
Sponsors and CROs may review essential documents, informed consent procedures, SOPs, and recordkeeping practices. The site must demonstrate that its procedures align with the protocol, applicable regulations, and Good Clinical Practice (GCP).
How to Prepare for a Site Qualification Visit
Preparation should begin before the scheduled meeting. Rather than gathering documents at the last minute, the PI and research team should review the study requirements.
Furthermore, they should also identify any gaps that could affect their ability to conduct the study.
Review the Protocol and Study Requirements
Understand the study population, eligibility criteria, procedures, and expected workload. Assess whether the site's resources align with the requirements. Reviewing site feasibility in clinical trials can help identify potential limitations early.
Organize Essential Documents
Gather relevant documentation that the sponsor or CRO may request, such as:
Current CVs and professional licenses, where applicable.
Investigator and staff training records.
Relevant SOPs.
Facility and equipment information.
Equipment maintenance and calibration records, where applicable.
Information about ethics committee or IRB arrangements.
Details of relevant research experience.
The sponsor may provide a specific document request list. Follow that list rather than assuming every study requires identical records.
Prepare the Research Team
Ensure the PI, coordinator, and relevant staff understand the protocol and their responsibilities. Discuss recruitment, participant visits, and study procedures in advance.
For newer sites, understanding how to start a clinical research site can help establish the operational foundation needed for clinical study start up.
Review Facilities and Equipment
Inspect the research areas and confirm that required equipment is available and functional. Review maintenance records, storage conditions, and access controls. Identify any gaps early and be transparent about resources that are still needed.
Site Qualification Visit Checklist
Use this site qualification visit checklist to organize the team's preparation before the scheduled assessment. The sponsor's instructions and protocol should always take priority over this general reference.
Preparation area | What to review |
Investigator readiness | Current CV, qualifications, experience, and availability. |
Staff readiness | Relevant training, experience, and proposed responsibilities. |
Study understanding | Protocol overview, eligibility criteria, and study procedures. |
Documentation | Applicable SOPs, training records, and essential documents. |
Facilities | Examination rooms, laboratory areas, and research workspaces. |
Equipment | Availability, maintenance, and calibration records where applicable. |
Storage | Appropriate storage arrangements and access controls. |
Participant management | Recruitment approach, scheduling, and safety procedures. |
Team coordination | Key attendees, assigned discussion areas, and anticipated questions. |
Follow-up preparation | Process for addressing questions and providing additional information. |
Completing this review does not guarantee qualification. It helps the site identify missing information and prepare clear responses before the sponsor or CRO arrives.
What Happens After the Site Qualification Visit in Clinical Trials?
After the visit, the sponsor or CRO may review its findings and request additional information. The site may need to clarify certain procedures, provide missing documentation, or address operational gaps.
This review can extend the qualification timeline beyond the visit itself. A Tufts CSDD study published in Applied Clinical Trials reported an average of 31.1 days for the overall site qualification process, covering preparation, the visit, and post-visit communication.
The outcome can vary. The sponsor may consider the site suitable, request follow-up actions, or decide that it does not meet the requirements of the proposed study.
If the site moves forward, additional steps may include budget and contract finalization, ethics committee or IRB review, and other regulatory requirements.
The site then progresses toward clinical trial site activation. This involves confirming that the necessary approvals, training, and study arrangements are in place before enrollment begins.
An SQV alone does not authorize a site to recruit or enroll participants.
Site Qualification Visit Best Practices for Researchers
A few practical habits can make the assessment more productive:
Be accurate: Present the site's actual staffing, experience, and resources.
Stay organized: Keep requested documents accessible and up to date.
Communicate clearly: Give direct answers and ask questions when requirements are unclear.
Involve the right people: Make sure relevant staff can explain their responsibilities.
Address gaps early: Identify missing resources or training before the visit.
Follow up promptly: Respond to additional requests and document agreed next steps.
These site qualification visit best practices help the sponsor or CRO understand how the site operates and what support or preparation may still be needed.
How CSRS Supports Clinical Research Site Readiness
Preparing for a site qualification visit requires more than organized documentation. Research sites also need a clear understanding of clinical research operations, appropriate workflows, and the knowledge to meet study requirements.
Based in Southeast Missouri, Clinical Science Research Solutions (CSRS) supports individuals and emerging research sites through education, site development, and mentorship.
Our Research Naive Institute Course introduces learners to clinical research, while its Site Ownership Program and entrepreneurial mentorship program provide guidance on building and growing research operations.
For those looking to enter clinical research or strengthen an emerging site, explore CSRS's programs to learn how education and mentorship can support the next steps.
Conclusion
A site qualification visit (SQV) allows research teams to demonstrate their readiness for a specific clinical trial. Reviewing the protocol, organizing documents, preparing staff, and checking facilities can make the process more straightforward.
Most importantly, sites should present their capabilities accurately and address gaps before moving toward activation.
Frequently Asked Questions
What is the main purpose of a site qualification visit in clinical trials?
A site qualification visit assesses whether a research site has the qualified staff, facilities, equipment, and operational resources needed to conduct a specific clinical trial.
Who conducts a site qualification visit in clinical trials?
A clinical trial sponsor or its contract research organization (CRO) typically conducts the visit through a sponsor representative or clinical research associate (CRA).
How long does a site qualification visit take?
The duration depends on the study's complexity, site size, and scope of assessment. The sponsor or CRO determines the schedule based on the areas that need review.
What is the difference between a site feasibility visit and a site qualification visit?
A feasibility assessment evaluates whether a site is a suitable potential location for a study. An SQV provides a closer assessment of the site's staff, facilities, documentation, and operational capabilities.
What happens if a research site does not pass an SQV?
The sponsor may request additional documentation, corrective actions, or improvements. If the site cannot meet the study requirements, it may not be selected for the trial.
How can new research sites prepare for an SQV?
New research sites should review the protocol, organize essential documents, prepare staff, assess facilities, and identify operational gaps. Clinical research education and mentorship can also help build site readiness.
Comments